Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
about
Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trialsClinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus.Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.Efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in black/African American patients with type 2 diabetes: Pooled analysis from eight Phase III trials.Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials.Letter to the editor regarding: "Pharmacokinetics of teneligliptin in subjects with renal impairment." Halabi et al., Clinical Pharmacology in Drug Development 2013;2:246-254.
P2860
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
@ast
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
@en
type
label
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
@ast
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
@en
prefLabel
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
@ast
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
@en
P2860
P356
P1476
Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials.
@en
P2093
Janet B McGill
P2860
P304
P356
10.1177/2042018812449406
P577
2012-08-01T00:00:00Z